Review Article
Volume 8 Issue 2 - 2021
The Role of Lactobacillus Probiotics in Dysentery
Alok Kumar Paul1,2, Anita Paul3, Khoshnur Jannat4, Sumona Afrose3, Tohmina Afroze Bondhon4, Anamul Hasan4, Rownak Jahan4 and Mohammed Rahmatullah4*
1University of Tasmania, Australia
2Quality Control and Research Laboratory, Essential Oils of Tasmania, Australia
3Department of Pharmacy, University of Development Alternative, Dhaka, Bangladesh
4Department of Biotechnology and Genetic Engineering, University of Development Alternative, Bangladesh
*Corresponding Author: Mohammed Rahmatullah, Department of Biotechnology and Genetic Engineering, University of Development Alternative, Bangladesh.
Received: December 04, 2020; Published: January 22, 2021


Dysentery is a gastrointestinal infection characterized by mucus and blood with stool usually caused by bacteria and parasites from contaminated food and water with faeces. The disease is widely recorded in developing countries, especially with poor health and hygiene conditions. Shigellosis and amoebiasis are two major types of dysentery that cause upsetting gastrointestinal microbial flora essential for proper digestions. Diarrhoea, pain, fever, and feeling of incomplete defecation are common symptoms of dysentery. Probiotics, especially Lactobacillus spp. are currently used in diarrhoea and indigestions to improve digestive health, grow immunity, and general well-being. The actual mechanism of action of Lactobacillus spp. is still not precise in the literature. In this review, we summarise the findings of recent studies based on the roles of Lactobacillus spp. in the management of pathogens of bacillary and amoebic dysentery in clinical, preclinical, and in vitro studies.

Keywords: Diarrhoea; Dysentery; Probiotics; Lactobacillus; Shigellosis; Amoebiasis 


  1. Dysentery (2020).
  2. Dysentery (2020).
  3. Williams PC and Berkley JA. "Guidelines for the treatment of dysentery (shigellosis): a systematic review of the evidence". Paediatrics and International Child Health1 (2018): S50-S65.
  4. Ashkenazi S. "Shigella infections in children: new insights". Seminars in Pediatric Infectious Diseases4 (2004): 246-252.
  5. Phalipon A and Sansonetti PJ. "Shigella's ways of manipulating the host intestinal innate and adaptive immune system: a tool box for survival?" Immunology and Cell Biology2 (2007): 119-129.
  6. Zychlinsky A., et al. "Shigella flexneri induces apoptosis in infected macrophages". Nature6382 (1992): 167-169.
  7. Carneiro LA., et al. "Shigella induces mitochondrial dysfunction and cell death in nonmyleoid cells". Cell Host and Microbe2 (2009): 123-136.
  8. Schroeder GN and Hilbi H. "Molecular Pathogenesis of Shigella spp.: Controlling Host Cell Signaling, Invasion, and Death by Type III Secretion". Clinical Microbiology Reviews1 (2008): 134-156.
  9. Guidelines for the control of shigellosis, including epidemics due to Shigella dysenteriae type 1. (2005).
  10. Boirivant M and Strober W. "The mechanism of action of probiotics". Current Opinion in Gastroenterology6 (2007): 679-692.
  11. McFarland LV. "Epidemiology, risk factors and treatments for antibiotic-associated diarrhea". Digestive Diseases5 (1998): 292-307.
  12. Barbut F and Meynard JL. "Managing antibiotic associated diarrhoea". British Medical Journal7350 (2002): 1345-1346.
  13. Cremonini F., et al. "Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea". Alimentary Pharmacology and Therapeutics8 (2002): 1461-1467.
  14. Darton TC., et al. "Azithromycin Resistance in Shigella spp. in Southeast Asia". Antimicrobial Agents and Chemotherapy4 (2018): e01748-17.
  15. Marie C and Petri WA Jr. "Amoebic dysentery". BMJ Clinical Evidence 2013 (2013).
  16. Dans LF and Martínez EG. "Amoebic dysentery". BMJ Clinical Evidence 2007 (2007): 0918.
  17. Davis AN., et al. "Update on protozoan parasites of the intestine". Current Opinion in Gastroenterology1 (2002): 10-14.
  18. Nakada-Tsukui K and Nozaki T. "Immune Response of Amebiasis and Immune Evasion by Entamoeba histolytica". Frontiers in Immunology 7 (2016): 175.
  19. Ranjbar R and Farahani A. "Shigella: Antibiotic-Resistance Mechanisms And New Horizons For Treatment". Infection and Drug Resistance 12 (2019): 3137-3167.
  20. Shad AA and Shad WA. "Shigella sonnei: virulence and antibiotic resistance". Archives of Microbiology (2020): 1-14.
  21. Fenster K., et al. "The Production and Delivery of Probiotics: A Review of a Practical Approach". Microorganisms3 (2019): 83.
  22. Sreeja V and Prajapati JB. "Probiotic Formulations: Application and Status as Pharmaceuticals-A Review". Probiotics Antimicrobial Proteins2 (2013): 81-91.
  23. Kahbazi M., et al. "Efficacy of Synbiotics for Treatment of Bacillary Dysentery in Children: A Double-Blind, Randomized, Placebo-Controlled Study". Advances in Medicine 2016 (2016): 3194010.
  24. FAO/WHO. "Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria". Prevention1 (2001): 1-10.
  25. "Probiotics: What You Need To Know": National Center for Complementary and Integrative Health, US National Institutes of Health (2019).
  26. Sharif A., et al. "The Role of Probiotics in the Treatment of Dysentery: a Randomized Double-Blind Clinical Trial". Probiotics Antimicrobial Proteins 4 (2017): 380-385.
  27. Martinez RM., et al. "Molecular analysis and clinical significance of Lactobacillus spp. recovered from clinical specimens presumptively associated with disease". Journal of Clinical Microbiology 1 (2014): 30-36.
  28. Lebeer S., et al. "Genes and molecules of lactobacilli supporting probiotic action". Microbiology and Molecular Biology Reviews 4 (2008): 728-764.
  29. Karczewski J., et al. "Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier". American Journal of Physiology-Gastrointestinal and Liver Physiology 6 (2010): G851-G859.
  30. Yeung C-Y., et al. "In Vitro Prevention of Salmonella Lipopolysaccharide-Induced Damages in Epithelial Barrier Function by Various Lactobacillus Strains". Gastroenterology Research and Practice 2013 (2013): 973209.
  31. Lam EKY., et al. "Enhancement of gastric mucosal integrity by Lactobacillus rhamnosus GG". Life Sciences23 (2007): 2128-2136.
  32. Kakisu E., et al. "Lactobacillus plantarum isolated from kefir: Protection of cultured Hep-2 cells against Shigella invasion". International Dairy Journal1 (2013): 22-26.
  33. Mangell P., et al. "Lactobacillus plantarum 299v inhibits Escherichia coli-induced intestinal permeability". Digestive Diseases and Sciences3 (2002): 511-516.
  34. Eizaguirre I., et al. "Probiotic supplementation reduces the risk of bacterial translocation in experimental short bowel syndrome". Journal of Pediatric Surgery5 (2002): 699-702.
  35. Hong SW., et al. "Selection and characterization of broad-spectrum antibacterial substance-producing Lactobacillus curvatus PA40 as a potential probiotic for feed additives". Animal Science Journal10 (2018): 1459-1467.
  36. De Keersmaecker SC., et al. "Strong antimicrobial activity of Lactobacillus rhamnosus GG against Salmonella typhimurium is due to accumulation of lactic acid". FEMS Microbiology Letters1 (2006): 89-96.
  37. Markowiak-Kopeć P and Śliżewska K. "The Effect of Probiotics on the Production of Short-Chain Fatty Acids by Human Intestinal Microbiome". Nutrients4 (2020): 1107.
  38. Wang L., et al. "Antibacterial activity of Lactobacillus plantarum isolated from Tibetan yaks". Microbial Pathogenesis 115 (2018): 293-298.
  39. Chen C-C., et al. "Antimicrobial Activity of Lactobacillus Species Against Carbapenem-Resistant Enterobacteriaceae". Frontiers in Microbiology 10 (2019): 789.
  40. Omar AM., et al. "Breaking Bad: a case of Lactobacillus bacteremia and liver abscess". Journal of Community Hospital Internal Medicine Perspectives3 (2019): 235-239.
  41. Salminen MK., et al. "Lactobacillus Bacteremia, Clinical Significance, and Patient Outcome, with Special Focus on Probiotic L. rhamnosus GG". Clinical Infectious Diseases1 (2004): 62-69.
  42. Sherid M., et al. "Liver abscess and bacteremia caused by lactobacillus: role of probiotics? Case report and review of the literature". BMC Gastroenterology1 (2016): 138.
  43. Li X-Q., et al. "Risks Associated with High-Dose Lactobacillus rhamnosus in an Escherichia coli Model of Piglet Diarrhoea: Intestinal Microbiota and Immune Imbalances". PLoS One 7 (2012): e40666.
  44. De Macías MEN., et al. "Inhibition of Shigella sonnei by Lactobacillus casei and Lact. acidophilus". Journal of Applied Bacteriology 5 (1992): 407-411.
  45. Huang C., et al. "Effects of Lactobacilli on the performance, diarrhea incidence, VFA concentration and gastrointestinal microbial flora of weaning pigs". Asian-Australasian Journal of Animal Sciences 3 (2004): 401-409.
  46. Tien MT., et al. "Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells". Journal of Immunology 2 (2006): 1228-1237.
  47. Moorthy G., et al. "Protective role of lactobacilli in Shigella dysenteriae 1-induced diarrhea in rats". Nutrition 5 (2007): 424-433.
  48. Bernardeau M., et al. "In vitro antagonistic activities of Lactobacillus spp. against Brachyspira hyodysenteriae and Brachyspira pilosicoli". Veterinary Microbiology1-2 (2009): 184-190.
  49. Kim HG., et al. "Lactobacillus plantarum lipoteichoic acid down-regulated Shigella flexneri peptidoglycan-induced inflammation". Molecular Immunology4 (2011): 382-391.
  50. Verma AK., et al. "Real-time analysis of gut flora in Entamoeba histolytica infected patients of Northern India". BMC Microbiology 12 (2012): 183.
  51. Mirnejad R., et al. "The antimicrobial effect of lactobacillus casei culture supernatant against multiple drug resistant clinical isolates of Shigella sonnei and Shigella flexneri in vitro”. Iran Red Crescent Medical Journal2 (2013): 122-126.
  52. Kedia S., et al. "Gut microbiome diversity in acute infective and chronic inflammatory gastrointestinal diseases in North India". Journal of Gastroenterology7 (2016): 660-671.
  53. Rani R., et al. "Changes in bacterial profile during amebiasis: demonstration of anaerobic bacteria in ALA pus samples". American Journal of Tropical Medicine and Hygiene5 (2006): 880-885.
  54. Trikha R., et al. "Remediation of intramacrophageal Shigella dysenteriae type 1 by probiotic lactobacilli isolated from human infants' stool samples". Indian Journal of Medical Research5 (2017): 679-686.
  55. Sarjapuram N., et al. "The Potential of Lactobacillus casei and Entercoccus faecium Combination as a Preventive Probiotic Against Entamoeba". Probiotics and Antimicrobial Proteins2 (2017): 142-149.
  56. Kota RK., et al. "Recent Advances in Probiotics as Live Biotherapeutics Against Gastrointestinal Diseases". Current Pharmaceutical Design27 (2018): 3162-3171.
  57. Cuellar-Guevara FL., et al. "Effect of Lactobacillus postbiotics on Entamoeba Histolytica trophozoites". Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion6 (2019): 402-407.
  58. Iyer LR., et al. "Phagocytosis of Gut Bacteria by Entamoeba histolytica". Frontiers in Cellular and Infection Microbiology 9 (2019): 34.
  59. Alamdary SZ and Bakhshi B. "Lactobacillus acidophilus attenuates toxin production by Vibrio cholerae and Shigella dysenteriae following intestinal epithelial cells infection". Microbial Pathogenesis 149 (2020): 104543.
  60. Song Y., et al. "Antibiofilm activity of Lactobacillus plantarum 12 exopolysaccharides against Shigella flexneri". Applied and Environmental Microbiology15 (2020): e00694-e00620.
  61. Yang J., et al. "Dynamic comparison of gut microbiota of mice infected with Shigella flexneri via two different infective routes". Experimental and Therapeutic Medicine3 (2020): 2273-2281.
Citation: Mohammed Rahmatullah., et al. “The Role of Lactobacillus Probiotics in Dysentery”. EC Gastroenterology and Digestive System 8.2 (2021): 78-85.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

April Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the April issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for upcoming Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before April 26, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to